会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 4. 发明授权
    • Process for producing fused imidazole compound, reformatsky reagent in stable form, and process for producing the same
    • 稠合咪唑化合物的制备方法,稳定形式的重格列烷基试剂及其制备方法
    • US08093403B2
    • 2012-01-10
    • US12648022
    • 2009-12-28
    • Jun-Ichi KawakamiShigeru NuwaShokyo Miki
    • Jun-Ichi KawakamiShigeru NuwaShokyo Miki
    • C07D233/64
    • C07D233/64C07D487/04C07F3/06
    • The present invention provides an industrially advantageous process for producing a steroid C17,20 lyase inhibitor represented by the general formula (I); and a Reformatsky reagent in a stable form suitable for the process. In the present invention, a compound represented by the general formula (I) is produced by reducing a specific β-hydroxy ester compound derivative or a salt thereof obtained from a specific carbonyl compound in a Reformatsky reaction in the presence of a metal hydride complex and a metal halide, and then subjecting it to a ring-closing reaction. In the above Reformatsky reaction, it is useful to use a stable solution of a compound represented by the general formula BrZnCH2COOC2H5 or a crystal of the compound which is represented by the formula (BrZnCH2COOC2H5.THF)2.
    • 本发明提供了用于生产由通式(I)表示的类固醇C17,20裂解酶抑制剂的工业上有利的方法; 和一种适用于该方法的稳定形式的Reformatsky试剂。 在本发明中,通式(I)表示的化合物是通过在金属氢化物络合物的存在下,通过在Reformatsky反应中还原由特定的羰基化合物得到的特定的β-羟基酯化合物衍生物或其盐 和金属卤化物,然后使其进行闭环反应。 在上述Reformatsky反应中,使用由通式BrZnCH 2 COOC 2 H 5表示的化合物或由式(BrZnCH2COOC2H5.THF)2表示的化合物的晶体的稳定溶液是有用的。